A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus

Frontiers in Cellular and Infection Microbiology
Can ChenLei Sun

Abstract

Interferon (IFN)-sensitive and replication-incompetent influenza viruses are likely to be the alternatives to inactivated and attenuated virus vaccines. Some IFN-sensitive influenza vaccine candidates with modified non-structural protein 1 (NS1) are highly attenuated in IFN-competent hosts but induce robust antiviral immune responses. However, little research has been done on the manufacturability of these IFN-sensitive vaccine viruses. Here, RIG-I-knockout 293T cells were used to package the IFN-sensitive influenza A/WSN/33 (H1N1) virus expressing the mutant NS1 R38A/K41A. We found that the packaging efficiency of the NS1 R38A/K41A virus in RIG-I-knockout 293T cells was much higher than that in 293T cells. Moreover, the NS1 R38A/K41A virus almost lost its IFN antagonist activity and could no longer replicate in A549, MDCK, and Vero cells after 3-6 passages. This indicated that the replication of NS1 R38A/K41A virus is limited in conventional cells. Therefore, we further established a stable Vero cell line expressing the wild-type (WT) NS1 of the WSN virus, based on the Tet-On 3G system. The NS1 R38A/K41A virus was able to steadily propagate in this IFN-deficient cell line for at least 20 passages. In a mouse model, the NS1 R38...Continue Reading

References

Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·T P KoestlerG Poste
Mar 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·J TalonP Palese
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 22, 2002·The Journal of General Virology·Agustín Portela, Paul Digard
Jun 16, 2005·Journal of Virological Methods·Stéphane BiacchesiUrsula J Buchholz
Apr 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ji-Young Min, Robert M Krug
Jan 6, 2007·The Journal of Biological Chemistry·Kazuhide OnoguchiTakashi Fujita
Sep 18, 2007·The Journal of General Virology·Alexey A Matskevich, Karin Moelling
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kalyan DasGaetano T Montelione
Oct 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michaela U GackJae U Jung
May 21, 2009·Cell Host & Microbe·Michaela Ulrike GackAdolfo García-Sastre
Jun 15, 2010·Cell Host & Microbe·Tokiko WatanabeYoshihiro Kawaoka
Jul 27, 2010·Cytokine & Growth Factor Reviews·Katrin WitteKerstin Wolk
Dec 14, 2012·Journal of Virology·Yukiko MuramotoYoshihiro Kawaoka

❮ Previous
Next ❯

Citations

Mar 1, 2019·Viruses·Pilar Blanco-LoboLuis Martínez-Sobrido
Jan 17, 2020·Nature·Hannah G HamptonPeter C Fineran
Apr 12, 2021·Biochemical and Biophysical Research Communications·Lifen ZhaoShufen Li

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
Assay
co-IP

Related Concepts

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.